BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37004423)

  • 41.
    Mustansar T; Mirza T; Hussain M
    Biotech Histochem; 2023 Nov; 98(6):382-390. PubMed ID: 37013448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
    Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
    [No Abstract]   [Full Text] [Related]  

  • 43. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
    Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
    J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [MicroRNA model that can predict the prognosis of oral squamous cell carcinoma based on bioinformatics analysis].
    Zhao G; Li CX; Guo C; Zhu H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Dec; 38(6):622-627. PubMed ID: 33377337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
    Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
    Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
    Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
    Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.
    Wan X; Li X; Yang J; Lv W; Wang Q; Chen Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(10):13360-6. PubMed ID: 26722541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
    Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
    Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.
    Bigagli E; Locatello LG; Di Stadio A; Maggiore G; Valdarnini F; Bambi F; Gallo O; Luceri C
    J Oral Pathol Med; 2022 Apr; 51(4):350-357. PubMed ID: 34800057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.